ReviewInflammopharmacology2026

Targeting NF-κB and JAK/STAT pathways in rheumatoid arthritis: emerging nanocarrier-based drug delivery approaches.

G Surendra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.